129 related articles for article (PubMed ID: 24123335)
1. Gadolinium-based contrast agents: what does "single-dose" mean anymore?
Reeder SB
J Magn Reson Imaging; 2014 Jun; 39(6):1343-5. PubMed ID: 24123335
[No Abstract] [Full Text] [Related]
2. Late Gadolinium Enhancement in Cardiovascular MR Imaging.
Case DC
Radiol Technol; 2019 Sep; 91(1):71-74. PubMed ID: 31471479
[No Abstract] [Full Text] [Related]
3. Extracellular gadolinium-based contrast media: differences in diagnostic efficacy.
van der Molen AJ; Bellin MF
Eur J Radiol; 2008 May; 66(2):168-74. PubMed ID: 18372137
[TBL] [Abstract][Full Text] [Related]
4. Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions.
Mathews VP; Caldemeyer KS; Ulmer JL; Nguyen H; Yuh WT
J Magn Reson Imaging; 1997; 7(1):14-22. PubMed ID: 9039589
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging using gadolinium-based contrast agents.
Mitsumori LM; Bhargava P; Essig M; Maki JH
Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
[TBL] [Abstract][Full Text] [Related]
7. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
[TBL] [Abstract][Full Text] [Related]
8. Technique for MR imaging of the liver.
Saini S; Nelson RC
Radiology; 1995 Dec; 197(3):575-7. PubMed ID: 7480718
[No Abstract] [Full Text] [Related]
9. Safety risks with gadolinium-based contrast agents.
Marzella L; Blank M; Gelperin K; Johann-Liang R
J Magn Reson Imaging; 2007 Sep; 26(3):816; author reply 817. PubMed ID: 17685423
[No Abstract] [Full Text] [Related]
10. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.
Cummings KW; Bhalla S; Javidan-Nejad C; Bierhals AJ; Gutierrez FR; Woodard PK
Radiographics; 2009; 29(1):89-103. PubMed ID: 19168838
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview.
Kanal E
Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):625-31. PubMed ID: 23088942
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium contrast agent selection and optimal use for body MR imaging.
Guglielmo FF; Mitchell DG; Gupta S
Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of focal liver lesions.
Schnall M
Semin Roentgenol; 1995 Oct; 30(4):347-61. PubMed ID: 8539644
[No Abstract] [Full Text] [Related]
15. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
16. Comparison study of intraarticular and intravenous gadolinium-enhanced magnetic resonance imaging of cartilage in a canine model.
Kwack KS; Cho JH; Kim M MS; Yoon CS; Yoon YS; Choi JW; Kwon JW; Min BH; Sun JS; Kim SY
Acta Radiol; 2008 Feb; 49(1):65-74. PubMed ID: 17963083
[TBL] [Abstract][Full Text] [Related]
17. Use of magnetic resonance imaging contrast agents in the liver and biliary tract.
Lebedis C; Luna A; Soto JA
Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947
[TBL] [Abstract][Full Text] [Related]
18. Review of the use of high-dose gadoteridol in the magnetic resonance evaluation of central nervous system tumors.
Yuh WT; Fisher DJ; Mayr-Yuh NA; Tali ET; Nguyen HD; Gao F; Ehrhardt JC
Invest Radiol; 1992 Aug; 27 Suppl 1():S39-44. PubMed ID: 1506152
[No Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
20. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
